Back to top
more

Waters (WAT)

(Delayed Data from NYSE)

$386.69 USD

386.69
669,008

-0.48 (-0.12%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $386.53 -0.16 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Instruments

Zacks News

Waters Stock Gains on Earnings & Sales Beat in Q3, Raised View

WAT's third-quarter 2024 results show growth in the pharma and industrial sectors. A dip in China sales creates headwinds.

Waters (WAT) Beats Q3 Earnings and Revenue Estimates

Waters (WAT) delivered earnings and revenue surprises of 9.33% and 3.65%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Tactile Systems Technology (TCMD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Tactile Systems Technology (TCMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Waters (WAT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Waters (WAT) is Poised to Beat Earnings Estimates Again

Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Is Waters (WAT) Down 2.2% Since Last Earnings Report?

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Deciphering Waters (WAT) International Revenue Trends

Explore how Waters' (WAT) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Waters (WAT) Q2 Earnings & Sales Beat Estimates, Fall Y/Y

Waters' (WAT) second-quarter results are hurt by weak end-market momentum and softness in Asia, Americas and Europe.

Compared to Estimates, Waters (WAT) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Waters (WAT) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Waters (WAT) Q2 Earnings and Revenues Top Estimates

Waters (WAT) delivered earnings and revenue surprises of 3.14% and 1.51%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?

Sensus Healthcare (SRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Waters (WAT) to Report Q2 Earnings: What's in the Offing?

Waters' (WAT) second-quarter 2024 results are likely to reflect strength in the large molecule and PFAS testing markets amid weakening demand in China.

Analysts Estimate Waters (WAT) to Report a Decline in Earnings: What to Look Out for

Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IQV vs. WAT: Which Stock Should Value Investors Buy Now?

IQV vs. WAT: Which Stock Is the Better Value Option?

Agilent (A) Boosts Reach to Lab Researchers With New Devices

Agilent (A) boosts its presence in the mass spectrometry market with the launch of the Agilent 7010D Triple Quadrupole GC/MS System and the Agilent ExD Cell.

Why Is Waters (WAT) Down 5.1% Since Last Earnings Report?

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Waters (WAT) Expands Mass Spectrometer Portfolio With Xevo MRT

Waters (WAT) boosts MS offerings with the launch of Xevo MRT, strengthening its Waters operating segment's portfolio.

Waters (WAT) International Revenue in Focus: Trends and Expectations

Examine Waters' (WAT) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Waters (WAT) Q1 Earnings & Sales Beat Estimates, Fall Y/Y

Waters' (WAT) first-quarter results are hurt by weak end-market momentum and softness in Asia.

Compared to Estimates, Waters (WAT) Q1 Earnings: A Look at Key Metrics

The headline numbers for Waters (WAT) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates

Si-Bone (SIBN) delivered earnings and revenue surprises of 6.90% and 3.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Waters (WAT) to Report Q1 Earnings: What's in the Offing?

Waters' (WAT) first-quarter 2024 results are likely to reflect strength in the large molecule and PFAS testing markets amid weakening demand in China.

Will Accelerate Diagnostics (AXDX) Report Negative Q1 Earnings? What You Should Know

Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Unlocking Q1 Potential of Waters (WAT): Exploring Wall Street Estimates for Key Metrics

Beyond analysts' top -and-bottom-line estimates for Waters (WAT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.

Earnings Preview: Waters (WAT) Q1 Earnings Expected to Decline

Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.